ANIK

NASDAQStock

Anika Therapeutics, Inc.

$14.17-0.13 (-0.91%)

52-Week Range

$8.10

$16.11

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.30

Volume

75.7K

Avg Volume

169.5K

Performance

+42.15%

+49.43%

+65.32%

YTD

+52.94%

-10.12%

-46.88%

-61.97%

Price Chart

ETF Exposure

ANIK is held by 60 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SCHB	Schwab U.S. Broad Market ETF	0.00%	8,500	$120K	$37.50B	0.03%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	21	$263	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	752	$9K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	3	$45	$337.7M	0.32%
VTHR	Vanguard Russell 3000 ETF	0.00%	1,066	$10K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	428,624	$4.0M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	2,254	$28K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	194	$2K	$1.29B	0.17%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	46,124	$52K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	46,124	$16K	$3.91B	0.07%

PreviousPage 2 of 2

About ANIK ETF Exposure

Anika Therapeutics, Inc. (ANIK) is held by 60 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $14.17. Investors can gain exposure to ANIK through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ANIK, sorted by portfolio weight.